Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Dow
Boehringer Ingelheim
QuintilesIMS
Citi
Julphar
McKesson
US Department of Justice

Generated: December 14, 2018

DrugPatentWatch Database Preview

NOCTIVA Drug Profile

« Back to Dashboard

When do Noctiva patents expire, and when can generic versions of Noctiva launch?

Noctiva is a drug marketed by Avadel Speclt and is included in one NDA. There are four patents protecting this drug.

This drug has eighty-nine patent family members in thirty countries.

The generic ingredient in NOCTIVA is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.

Drug patent expirations by year for NOCTIVA
Synonyms for NOCTIVA
[deamino-Cys1,D-Arg8]vasopressin
[deamino-Cys1]AVP
[deamino1]AVP
1-{[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyl-n5-(diaminomethylidene)ornithylglycinamide
1-deamino,D-AVP
1-Desamino-8-arginine Vasopressin
1-Desamino-8-D-arginine vasopressin
6917-99-3
A810770
AC1L1EDS
AC1Q5JBY
Adiuretin
Adiuretin SD
BDBM85094
C06944
C4H10.CH2O
CAS_62357-86-2
CHEMBL264448
CS-1199
D00291
D0N9GI
D0U7SH
D0Y7SJ
dAVP
DDAVP
Deamino Arginine Vasopressin
Deamino-8-D-arginine, l-, vasopressin
deamino-vasopressin
Desamino-8-D-arginine vasopressin, l-
Desmopresina [INN-Spanish]
Desmopressin (fast-dissolving, nocturia/diabetes insipidus)
Desmopressin (fast-dissolving, nocturia/diabetes insipidus), Ferring Pharmaceuticals
Desmopressin (INN)
Desmopressin [INN:BAN]
Desmopressin Melt
Desmopressin Monoacetate, Trihydrate
Desmopressine [INN-French]
Desmopressinum
Desmopressinum [INN-Latin]
EINECS 240-726-7
FE-992026
GTPL2181
GTPL2182
HY-17370A
L001026
LS-173612
LS-187262
Minirin
Minrin Melt
N-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-p
N-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacyc
N-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)1,2-dithia-5,8,11,14,17-pen
N-[1-[(2-azanyl-2-oxidanylidene-ethyl)amino]-5-[bis(azanyl)methylideneamino]-1-oxidanylidene-pentan-2-yl]-1-[[7-(2-azanyl-2-oxidanylidene-ethyl)-10-(3-azanyl-3-oxidanylidene-propyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-p
NSC_64759
SCHEMBL13575732
Vasopressin, 1-(3-mercaptopropanoic acid)-8-D-arginine-
Vasopressin, Deamino Arginine

US Patents and Regulatory Information for NOCTIVA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avadel Speclt NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-001 Mar 3, 2017 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Avadel Speclt NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-002 Mar 3, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Avadel Speclt NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-001 Mar 3, 2017 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Avadel Speclt NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-002 Mar 3, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for NOCTIVA

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2017000006 Germany ➤ Sign Up PRODUCT NAME: DESMOPRESSIN ODER DAS ACETAT DAVON; NAT. REGISTRATION NO/DATE: 94725.00.00 94726.00.00 20160901 FIRST REGISTRATION: BELGIEN BE497271 BE497280 20160504
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Dow
Johnson and Johnson
Federal Trade Commission
Chinese Patent Office
Farmers Insurance
Cipla
Julphar
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.